Abstract
Objective:
Neonatal seizures are common, difficult to diagnose and treat, and associated with a great mortality rate and long-term risk of neurodevelopmental impairments. We aimed to determine the etiology, clinical presentation, and neurodevelopmental outcome of neonatal seizures.
Materials and Methods:
In this cross-sectional study, 88 neonates, aged < 28 days, admitted to Mofid Children’s Hospital, Tehran, Iran, from September 2011 to 2013 with the initial diagnosis of seizure were enrolled by convenient sampling method. Data, including age, gestational age, birth weight, Apgar of the fifth minute, neonatal intensive care unit (NICU) admission, family history, type, cause, and age of seizure, EEG and paraclinic findings, anticonvulsant used for treatment, neurodevelopmental status, and the final outcome, were collected from medical records and the missed cases were completed by phone calls. The frequency and association of variables were analyzed using SPSS software.
Results:
Among neonates with seizures, 67% were male, 79.5% were born term, and 72.7% had normal birth weight. The most common type of seizure was multifocal clonic seizures (45.5%). The main diagnosis in neonates with seizures was hypoxic-ischemic encephalopathy (HIE) (23.9%) and hypoglycemia (10.22%). The mortality rate was 11.36% during a mean follow-up period of 21.4±6.4 months. Neurodevelopmental assessments showed that 64% were normal, 27% had global delay, and 9% had motor delay. Positive family history of epilepsy (P=0.006), low Apgar score (P=0.002) and epilepsy (P<0.001) were significantly associated with adverse neurodevelopmental outcome.
Conclusion:
Since HIE and hypoglycemia were the most common cause of neonatal seizures, efforts should be made to improve care during delivery and early breastfeeding.
Key Words: Newborn, Seizure, Etiology, Neurodevelopmental outcome
Introduction
Despite the tremendous development in medical sciences, and improvement of global health in recent decades, neonatal seizure is still a common phenomenon in neonates and is associated with high rate of morbidity and mortality (1). Neonatal seizure can be a benign transient phenomenon with favorable outcome and no recurrence, but it may be associated with neurodevelopmental disorders or be complicated with epilepsy later in the child’s life in about 30% of survive neonates (2).
Iranian studies have declared a prevalence of 2.4%-9% for neonatal seizure with a mortality rate of about 14% (3, 4), although studies in other countries have reported higher mortality rates (about 17%) (5, 6) and another study found no difference in mortality rate between neonates with seizure and neonates admitted to NICU without seizure (7). Thus, it seems necessary to dig out the reasons underlying the neonatal seizure and factors associated with its mortality.
Several risk factors for its occurrence, including preterm birth, maternal diabetes, and fetal distress, associated with the most common causes of neonatal seizure, including hypoxic-ischemic brain injury and hypoglycemia have been reported (8). Other risk factors for neonatal seizure include maternal hypothyroidism diagnosed after birth (9), and 5-min Apgar scores (10). Genetic factors also play a role in its incidence, as studies have identified the responsible mutations in familial neonatal seizures (11). Besides, abnormal electroencephalography (EEG), and cranial ultrasonography findings and presence of underlying diseases, such as congenital heart disease, have been associated with unfavorable neurodevelopmental outcome (12).
Diagnosis is nevertheless not an easy issue, as the most efficient diagnostic tools, such as video-EEG, are not easily performable (5), and available diagnostic tools, such as computed tomography (CT) and magnetic resonance imaging (MRI) have insufficient accuracy for diagnosis of all lesions (13). In addition, although EEG is the most commonly used diagnostic tool, the accuracy of results are observer-based and various systems have been suggested to increase its performance (14, 15); thus, studies have suggested a higher accuracy in using a combination of methods (13). Initial therapy by common medications seems to be ineffective (16), and the rate of neurodevelopmental disorders and mortality are high.
Assessing the combination of etiological factors, clinical presentation, different diagnostic tools, and treatments, as well as neurodevelopmental outcome can broad the physicians’ view towards neonatal seizure. Therefore, we aimed to investigate the clinical, paraclinical, and demographic details of neonatal seizure and the association with adverse neurological outcome in a referral pediatric center in Iran.
Materials and Methods
Study design
In this descriptive cross-sectional retro and prospective study, neonates referred to Mofid Children’s Hospital, Tehran, Iran from September 2011 to September 2013 were enrolled. The sample size was calculated at 80 cases and for the probability of lost to follow-up cases, 88 participants were enrolled based on convenient sampling method. All neonates, aged < 28 days, admitted to the hospital with initial diagnosis of seizure by pediatric neurologists and Neonatalogists were included and then followed for neurodevelopmental outcome. Any neonate who was not followed up was excluded from the study.
Ethics Committee of Shahid Beheshti University of Medical Sciences, Tehran, Iran approved the protocol. The ethical considerations of Helsinki’s declaration were met throughout the study.
Mofid Hospital is located in central Tehran, Iran, and is considered a referral center for pediatric diseases. Data, including sex, gestational age, age at seizure, birth weight (BW), type of delivery, 5-minute Apgar, NICU admission, need for mechanical ventilation, family history of neonatal seizure, the clinical manifestation of seizure, EEG and paraclinic findings, the status of seizure at the time of discharge, cause of seizure, type of anticonvulsant used for its treatment, neuro/physical developmental status, and the final outcome until discharge, were collected from medical records and the missed cases were completed by phone calls. All participants were followed by phone calls and out-patient visit.
HIE was defined according to the American College of Obstetricians and Gynecologists guidelines. BW was categorized to normal: 2500-4000 g, low (LBW): 1500-2499 g, and very low (VLBW) < 1500 g. As a routine care in this hospital, all EEGs are interpreted by expert child neurologist as normal, mildly abnormal, and moderately-to-severely abnormal and CT, and MRIs are reported by an expert radiologist. To identify the cause of seizure paraclinic tests were performed, including CSF results, electrolytes, metabolic screening tests, and fluid cultures that are examined by Mofid Hospital’s laboratory and are confirmed by the pathologist.
Statistical analysis
Descriptive analysis was used for presenting the results, including mean ± standard deviation (SD) for quantitative variables and frequency (percentage) for categorical variables. The association of variables were tested by Fisher’s exact test. For the statistical analysis, the statistical software SPSS software, version 16.0 for windows (SPSS Inc., Chicago, IL, USA) was used. P values of 0.05 or less were considered statistically significant.
Results
Among neonates with seizures, 66% were male. Most neonates with seizure (79.5%) were term, 12% were born at 34th-36th gestational week, and 8% were born < 34th gestational week; mean ±SD of gestational age was 36.99±1.33. Regarding birth weight, 72.7% had normal BW, 15.9% were LBW, 5.7% were VLBW, and 2% weighed over 4 kg, and 3% had IUGR; mean ±SD of birth weight was 2.89±0.58 . Regarding type of delivery, 69% were born through cesarean section, 24% were born by normal vaginal delivery (NVD), and 7% were born by NVD with problems. Only 25% had a positive family history of neonatal seizure.
The Apgar of the fifth minute was 7-10 in 72% of neonates, and < 7 in the rest 28%. Among all neonates, 73% had NICU admission and 23% required mechanical ventilation. Regarding seizure type, the most common type was multifocal clonic seizures (45.5%), 20% tonic, 13% focal clonic, 13% subtle, and 9% myoclonic seizure. The time of occurrence of seizure was in the first 24hours of life in 18.2% of neonates.
The results of EEG showed that 76% had normal to mildly abnormal EEG results and 24% moderately to severely abnormal findings. The results of LP showed that 15% had abnormal findings (pleocytosis, high protein and low sugar), and the results of CT/MRI showed that 50% had abnormal findings. Among abnormal findings of imaging 79.6% were in favor of vascular process (ischemia and stroke) and 4.6% structural brain anomaly and 15.8% unclassified findings.
The main diagnosis in neonates with seizures was cerebrovascular (29.5%) including HIE (23.9%), followed by metabolic (15.9%) including hypoglycemia (10.22%); and inborn error of metabolism (8%): 3 patients with organic academia, 2 with NKH (non-ketotic hyperglycinemia) and 2 with MSUD (maple syrup urine disease). The main etiologies of seizure are demonstrated in Figure 1. As shown, 39.8% were unknown, while the rest of causes were less than 10%.
Figure 1.
The main etiologies of seizure in the study population: IEM (Inborn Error of Metabolism), Structural Brain Diseases. Vertical( percent).
The main drugs used for controlling seizure included phenobarbital (76.1%), and phenytoin (35.2%), while the rest of drugs had a frequency of less than 10% (Figure 2) and 49% used monotherapy, while 25% used double therapies, and 26% used triple or more therapies. Among all patients, 87% were controlled at discharge and 10.2% were discharged by parents.
Figure 2.
The frequency of drugs used for controlling seizure in the studied patients. PB (Phenobarb), Phenito (Phenytoin), B6 (Vitamin B6), Leve (Levetiracetam), Top (Topiramate), Ca (Calcium), BDZ (Benzodiazepin). Vertical (percent
The mortality rate was 11.36%; the age of neonates at death are demonstrated in Figure 3. Mean follow-up was 21.4±6.4 (range: 9-34) months (Figure 4). During the follow-up period, 23% of neonates had repeated seizures after discharge, while 38% continued their anti-epileptic drug. Neurodevelopmental assessments showed that 64% were normal, 27% had global delay, and 9% had motor delay.
Figure 3.
The age of death of patients
Figure 4.
The frequency of duration of follow-up (per month
Positive family history of epilepsy, low Apgar score and epilepsy were significantly associated with adverse neurodevelopmental outcome, but the rest of variables were not (Table 1).
Table 1.
The association of demographic characteristics with neurodevelopmental status
| Variable | Category | Neurodevelopmental status | P -value | |
|---|---|---|---|---|
| Normal, N (%) | Delay, N (%) | |||
| Sex | Male | 37 (74) | 18 (64.3) | 0.441 |
| Female | 13 (26) | 10 (35.7) | ||
| Gestational age | Term | 41 (82) | 22 (78.6) | 0.769 |
| Preterm | 9 (18) | 6 (21.4) | ||
| Type of delivery | Cesarean section | 35 (70) | 20 (71.4) | 1.00 |
| NVD | 15 (30) | 8 (28.6) | ||
| Apgar of the 5 th minute | 7-10 | 44 (88) | 15 (53.6) | 0.002 |
| <7 | 6 (12) | 13 (46.4) | ||
| Family history | Positve | 7 (14) | 12 (42.9) | 0.006 |
| Negative | 43 (86) | 16 (57.1) | ||
| Duration of seizure | < 24 h | 6 (12) | 6 (21.4) | 0.332 |
| ≥24 h | 44 (88) | 22 (78.6) | ||
| Seizure after discharge | Controlled | 47 (94) | 13 (46.4) | <0.001 |
| Repeated | 3 (6) | 15 (53.6) | ||
Discussion
The results of the present study indicated a mortality rate of 11.36% during a mean follow-up period of 21.4±6.4 months among 88 neonates with seizures, who were male-dominant, and mostly born term with normal BW.
The mortality rate reported in the present study is in line with previous Iranian studies, reporting a mortality rate of about 13%-14% (3, 4, 17). It is noteworthy to mention that most studies have established HIE as the most common diagnosis (2-4, 17, 18), which is similar to the results of the present study, indicating the emergent necessity to pay more attention to neonatal/maternal care during delivery in Iran, as HIE is difficult to treat and associated with adverse outcome (19). In addition, the frequency of infection in the present study (5.7%) was lower than the study by Lai et al. in Taiwan (6) and an Iranian study in a rural area (7), both reporting a frequency of nearly 8%, and much lower than the study by Sabzehei and colleagues (24.4%) (3), while the percentage of unknown causes was higher in the present study than previous studies (3, 4, 6), which might be due to the high rate of neonates being discharged by parents (10.2%), and unwillingness to undergo LP (33%), and imaging (15.9%).
Early-onset seizure was identified as the most common time of occurrence in the present study, which is consistent with the results of previous studies (3, 20). Moreover, male-dominancy of neonates with seizure in the present have been reported in some previous studies (3, 6, 7, 17) that suggests more accurate investigations in male neonates, suspected of seizure.
The most common type of seizure in the results of the present study was multifocal clonic seizures (45.5%), which is similar to the results of the study by Gebremariam and colleagues, while some studies have reported subtle seizure as the most common type and clonic seizures as the second or third most common type of seizure (3, 4, 6), which might be due to the demographic and epidemiological differences in different studies or the accuracy of different diagnostic tools used. As the type of seizure is associated with long-term neurologic outcome (21), it is suggested that more accurate diagnostic tools be considered for appropriate diagnosis of neonatal seizure.
In the present study, adverse neurodevelopmental outcome occurred in 36% of patients, which was significantly associated with positive family history (P=0.006), low 5-minute Apgar score (P=0.002), and epilepsy (P<0.001) that necessitates proper education for mothers who have positive family history, in addition to paying more attention to neonatal care after delivery. Similarly, previous studies have reported 5-minute Apgar a reliable index of the adverse neurologic outcome (22-24), which is in line with the results of the current study, but another study has confirmed the association between gestational age and adverse outcome (22). Pisani and colleagues have designed a scoring system based on factors associated with adverse neurologic outcome, in order to be able to predict them, which mainly include birth weight, Apgar score, primary neurologic examination, cerebral ultrasound, efficacy of anticonvulsant therapy, and status epilepticus (25). The rate of adverse outcome of neonatal seizure had remained unchanged (18); therefore, it is essential that healthcare staff, including doctors and nurses, pay sufficient attention to the risk factors of neurodevelopmental delay, as proposed in the results of the present study, and educate mothers in this regard, as well, in order to be able to reduce the rate of this morbidity.
As posited, efficacy of anticonvulsant therapy is an important issue in occurrence of adverse neurologic outcome and multiple treatments have been suggested (25, 26), but the results on the most appropriate drug regimen seem to be controversial (27, 28). In the present study, the most commonly used drugs were phenobarbital and phenytoin, which resulted in 36% neurodevelopmental delay, while a higher rate of adverse neurologic outcome are reported by other studies (2, 6, 22). Notably, 13 cases in the present study received no treatment by the neurologist’s advice and stayed without seizure and without neurodevelopmental delay during follow-up. Therefore, it can be concluded that the treatment regimen used by pediatric neurologists in Mofid Hospital seems satisfactory.
Strengths and Limitations: The current study could investigate a combination of clinical, paraclinical, and demographic details of neonatal seizure and the adverse neurologic outcome in neonates referred to a central pediatric hospital. Yet, the present study had some limitations, as well. One of the limitations of the current study was the high rate of neonates being discharged by parents, and unwillingness to undergo further examination that resulted in lack of identification of the cause of seizure in several cases, which might have affected the results regarding the etiology of neonatal seizure. In addition, the retrospective nature of the study, beside the fact that data was collected from one center limited the generalizability of data.
In conclusion, the results of the present study indicated HIE and hypoglycemia as the most common causes of neonatal seizures, representing the necessity to take measures to improve care during delivery and early breast-feeding. In addition, the significant association of positive family history and 5-minute Apgar score with neurodevelopmental delay in long-term follow-up demands paying more attention to the maternal/neonatal care during delivery and precise history taking.
Acknowledgment
The authors of the present study sincerely thank Dr. Alipour and Mrs. Shahidi
Authors' Contribution
Hamid Nemati: Conception and design, data analysis, drafting and revising the manuscript, final approval of the manuscript, accountable for all aspects of the work, Corresponding Author.
Parvaneh Karimzadeh: Conception and design, data analysis, drafting and revising the manuscript, final approval of the manuscript, accountable for all aspects of the work.
Minoo Fallahi: Data acquisition, drafting and revising the manuscript, final approval of the manuscript, accountable for all aspects of the work, consultant.
Conflict of interest
The authors declare that there are no conflicts of interests.
References
- 1.Uria-Avellanal C, Marlow N, Rennie JM. Outcome following neonatal seizures. Semin Fetal Neonatal Med . 2013;18(4):224–32. doi: 10.1016/j.siny.2013.01.002. [DOI] [PubMed] [Google Scholar]
- 2.Ronen GM, Buckley D, Penney S, Streiner DL. Long-term prognosis in children with neonatal seizures A population-based study. Neurology. 6;69(19):1816–22. doi: 10.1212/01.wnl.0000279335.85797.2c. [DOI] [PubMed] [Google Scholar]
- 3.Sabzehei MK, Basiri B, Bazmamoun H. The etiology, clinical type, and short outcome of seizures in newbornshospitalized in Besat Hospital/Hamadan/Iran. Iran J Child Neurol. 2014 Spring;8(2):24–28. [PMC free article] [PubMed] [Google Scholar]
- 4.Moayedi AR, Zakeri S, Moayedi F. Neonatal seizures: Etiology and type. Iran J child Neurol . 2007:23–6. [Google Scholar]
- 5.Glass HC, Shellhaas RA, Wusthoff CJ, Chang T, Abend NS, Chu CJ, et al. Contemporary Profile of Seizures in Neonates: A Prospective Cohort Study. J Pediatr . 2016;174:98–103. doi: 10.1016/j.jpeds.2016.03.035. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.(6) Lai Y-H, Ho C-S, Chiu N-C, Tseng C-F, Huang Y-L. Prognostic factors of developmental outcome in neonatal seizures in term infants. Pediatr Neonatol . 2013;54(3):166–72. doi: 10.1016/j.pedneo.2013.01.001. [DOI] [PubMed] [Google Scholar]
- 7.Sadeghian A, Damghanian M, Shariati M. Neonatal seizures in a rural Iranian district hospital: etiologies, incidence and predicting factors. Acta Med Iran. 2012;50(11):760–4. [PubMed] [Google Scholar]
- 8.Hall DA, Wadwa RP, Goldenberg NA, Norris JM. Maternal Risk Factors for Term Neonatal Seizures: Population-Based Study in Colorado, 1989—2003. J Child Neurol . 2006;21(9):795–8. doi: 10.1177/08830738060210092001. [DOI] [PubMed] [Google Scholar]
- 9.Andersen SL, Laurberg P, Wu CS, Olsen J. Maternal thyroid dysfunction and risk of seizure in the child: a Danish nationwide cohort study. J Pregnancy. 2013;2013:636705. doi: 10.1155/2013/636705. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Sun Y, Vestergaard M, Pedersen CB, Christensen J, Olsen J. Apgar scores and long-term risk of epilepsy. Epidemiology 2006 May. 17(3):296–301. doi: 10.1097/01.ede.0000208478.47401.b6. [DOI] [PubMed] [Google Scholar]
- 11.Grinton BE, Heron SE, Pelekanos JT, Zuberi SM, Kivity S, Afawi Z, et al. Familial neonatal seizures in 36 families: Clinical and genetic features correlate with outcome. Epilepsia. 2015;56(7):1071–80. doi: 10.1111/epi.13020. [DOI] [PubMed] [Google Scholar]
- 12.Ramantani G. Neonatal epilepsy and underlying aetiology: to what extent do seizures and EEG abnormalities influence outcome? Epileptic Disord . 2013;15(4):365–75. doi: 10.1684/epd.2013.0619. [DOI] [PubMed] [Google Scholar]
- 13.Abend NS, Wusthoff CJ. Neonatal seizures and status epilepticus. J Clin Neurophysiol. 2012;29(5):441–8. doi: 10.1097/WNP.0b013e31826bd90d. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Temko A, Thomas E, Marnane W, Lightbody G, Boylan G. Performance assessment for EEG-based neonatal seizure detectors. Clin Neurophysiol . 2011;122(3):474–82. doi: 10.1016/j.clinph.2010.06.035. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Stevenson NJ, Clancy RR, Vanhatalo S, Rosén I, Rennie JM, Boylan GB. Interobserver agreement for neonatal seizure detection using multichannel EEG. Ann Clin Transl Neurol . 1;2(11):1002–11. doi: 10.1002/acn3.249. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Okumura A. The diagnosis and treatment of neonatal seizures. Chang Gung Med J . 2012;35(5):365–72. doi: 10.4103/2319-4170.105482. [DOI] [PubMed] [Google Scholar]
- 17.Eghbalian F, Rasuli B, Monsef F. Frequency, causes, and findings of brain CT scans of neonatal seizure at Besat hospital, Hamadan, Iran. Iran J Child Neurol. 2015;9(1):56–63. [PMC free article] [PubMed] [Google Scholar]
- 18.Tekgul H, Gauvreau K, Soul J, Murphy L, Robertson R, Stewart J, et al. The current etiologic profile and neurodevelopmental outcome of seizures in term newborn infants. Pediatrics . 2006;117(4):1270–80. doi: 10.1542/peds.2005-1178. [DOI] [PubMed] [Google Scholar]
- 19.Shetty J. Neonatal seizures in hypoxic–ischaemic encephalopathy–risks and benefits of anticonvulsant therapy. Dev Med Child Neurol. 2015;57 Suppl 3:40–3. doi: 10.1111/dmcn.12724. [DOI] [PubMed] [Google Scholar]
- 20.Faiz N, Malik M, Azam M, Afzal U. Etiology and type of neonatal seizures. Ann Pak Inst Med Sci . 2009;5(2):77–86. [Google Scholar]
- 21.Brunquell PJ, Glennon CM, DiMario FJ, Lerer T, Eisenfeld L. Prediction of outcome based on clinical seizure type in newborn infants. J Pediatr . 2002;140(6):707–12. doi: 10.1067/mpd.2002.124773. [DOI] [PubMed] [Google Scholar]
- 22.Anand V, Nair PM. Neonatal seizures: predictors of adverse outcome. J Pediatr Neurosci. 2014 May-Aug;9(2):97–99. doi: 10.4103/1817-1745.139261. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Pashmdarfard M, Amini M, Hassani Mehraban A. Participation of Iranian Cerebral Palsy Children in Life Areas: A Systematic Review. Iran J Child Neurol. Winter. 2017;11(1):1–12. [PMC free article] [PubMed] [Google Scholar]
- 24.Gebremariam A, Gutema Y, Leuel A, Fekadu H. Early-onset neonatal seizures: types, risk factors and short-term outcome. Ann of Trop Peds. 2006 Jun;26(2):127–31. doi: 10.1179/146532806X107476. [DOI] [PubMed] [Google Scholar]
- 25.Pisani F, Sisti L, Seri S. A scoring system for early prognostic assessment after neonatal seizures. Pediatrics 2009 Oct. 124(4):e580–7. doi: 10.1542/peds.2008-2087. [DOI] [PubMed] [Google Scholar]
- 26.Toet MC, Groenendaal F, Osredkar D, van Huffelen AC, de Vries LS. Postneonatal epilepsy following amplitude-integrated EEG-detected neonatal seizures. Pediatr Neurol. 2005;32(4):241–7. doi: 10.1016/j.pediatrneurol.2004.11.005. [DOI] [PubMed] [Google Scholar]
- 27.Hellström‐Westas L, Boylan G, Ågren J. Systematic review of neonatal seizure management strategies provides guidance on anti‐epileptic treatment. Acta Paediatr . 2015;104(2):123–9. doi: 10.1111/apa.12812. [DOI] [PubMed] [Google Scholar]
- 28.Glass HC, Wirrell E. Controversies in neonatal seizure management. J Child Neurol. 2009;24(5):591–9. doi: 10.1177/0883073808327832. [DOI] [PubMed] [Google Scholar]